Dr. Zdenko Herceg is a molecular biologist with the specialization in epigenetics and cancer research. He is currently Department and Group Head at International Agency for Research on Cancer (Lyon, France). Prior to joining IARC (1997), he was a post-doctoral scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. He earned his Ph.D. (in 1995) from the University of St Andrews (UK) in the field of oncogenic transformation of human epithelial cells. He has authored more than 120 original peer-reviewed research publications in the field of epigenetics, mechanisms of carcinogenesis, and cancer research. He is the principal investigator of a number of large international projects funded by European Union, NIH, Gates Foundation, French National Cancer Institute (INCA) and other major international and national research foundation. His research revealed a number of important conceptual breakthroughs in the fields of epigenetics and mechanisms of cancer development and he has received important international distinctions and awards. Recent research in his laboratory aims at better understanding of epigenetic mechanisms in human cancer and providing critical information for the development of novel epigenetics-based strategies for cancer prevention, early detection, and treatment.

List of Published Work:
https://scholar.google.com/citations?hl=en&user=T8GCNZkAAAAJ&view_op=list_works